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This article contains the full list of miRNAs expressed in cultured
mesenchymal stromal cells, which were isolated from human adipose
tissue. We provide here data regarding the effect of miR-92a over-
expression on MSCs viability and cellular content of HGF and
angiopoietin-1. These are followed by the data regarding the effect of
conditioned medium of MSC transfected with pre-miR-92a, anti-miR-
92a or scramble oligos on HUVEC viability as well as their tube for-
mation efﬁciency. We also demonstrate here data regarding the effect
of extracellular vesicle depletion from MSCs conditioned medium on
its ability to stimulate the tube formation by HUVEC. Data inter-
pretation and discussion can be found in Kalinina et al. (2015) [1].
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations TableSubject area Biology
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ow data was
acquiredIllumina Human v2 microRNA panel was used to obtain a list of evidently
expressed microRNAs. Capillary-like structures were assayed in 24 h under
the light microscope (Leica). Concentrations of HGF and angiopoetin-1 in
lysates of MSCs transfected with pre-miR-92a (Ambion), anti-miR-92a or
pre-miR negative control 1 were measured by ELISA kits (R&D Systems).ata format Analyzed
xperimental
factorsMSC nucleofected with pre-miR-92a, anti-miR-92a or scramble oligos; MSC
conditioned medium applied to HUVEC, recombinant human HGF addedxperimental
featuresmicroRNA content in adipose-derived mesenchymal stromal cells was ana-
lysed. Adipose-derived MSCs were nucleofected with pre-miR-92a, anti-miR-
92a or scramble oligos. HGF and angiopoietin-1 were measured in cell lysates
by ELISA. Conditioned medium of transfected cells was applied to HUVEC
and tube formation was assessed. Extracellular vesicles were depleted by
ultracentrifugation.ata source
locationLomonosov Moscow State University, Moscow, Russiaata accessibility Data with this articleDValue of the data List of microRNAs expressed in adipose-derived MSCs will help to develop new experiments to
study functional activities of these cells.
 Overexpression or down-regulation of miR-92a by nucleofection does not affect MSC viability.
 Our data point to HGF as a new target of miR-92a.1 Data
Using human microRNA v2 panel (Illumina) we have identiﬁed 586 miR species, which were
evidently expressed in MSCs (see Table 1).
We selected miR-92a as a one of the most abundant angio-miRs expressed in MSCs and conﬁrmed
its expression by real-time PCR [1]. Then, we overexpressed or down-regulated its content using
nucleofection. We examined viability of transfected cells, which was about 90% and did not differ
between cells transfected with pre-miR-92a, anti-miR-92a or scramble oilgos (Fig. 1).
We also analyzed the content of HGF and angiopoietin-1 in these cells and found that intracellular
content of HGF was 2.6 times lower in MSCs transfected with pre-miR-92a comparing to scramble
transfected cells; however, angiopoietin content within MSCs did not change signiﬁcantly (see Fig. 2).
We collected conditioned medium of MSCs transfected with pre-miR-92a, anti-miR-92a or
scramble oilgos, applied it to HUVEC and analyzed their viability. Conditioned medium of transfected
MSCs did not affect the viability of HUVEC (see Fig. 3), which was about 90%.
Addition of recombinant HGF but not angiopoietin-1 to the conditioned medium of MSCs trans-
fected with pre-miR-92a restored its ability to stimulate the tube formation by HUVEC (see Fig. 4).
We also examined if the suppressive effect of conditioned medium of MSCs, which overexpress
miR-92a, could be mediated by a direct transfer of this microRNA to endothelial cells by extracellular
vesicles. We removed these vesicles from conditioned medium by ultracentrifugation and analyzed
the effect of cleared medium on tube formation. Removal of extracellular vesicles completely abro-
gated the ability of conditioned medium to induce tube formation (see Fig. 5). Data interpretation and
discussion can be found in [1].
Table 1
List of microRNAs evidently expressed in adipose-derived MSC.
TargetID Mean SD
hsa-miR-1280 23567.3 480.0
hsa-miR-21 23136.3 781.4
hsa-let-7a 22779.0 692.8
hsa-miR-214 22123.8 804.3
solexa-3927-221 21213.3 1085.0
hsa-miR-221 20160.3 954.3
hsa-miR-23a 19960.5 719.2
hsa-miR-199a:9.1 19815.5 1912.1
hsa-miR-720 19392.3 513.3
hsa-let-7g 19323.3 974.2
hsa-miR-125b 18808.8 643.9
hsa-miR-24 18341.5 1204.0
HS_22.1 18187.5 961.4
hsa-let-7f 18114.5 609.4
hsa-miR-320d,hsa-miR-320b,hsa-miR-320a 18100.8 428.0
hsa-miR-1274b 17902.8 2536.3
hsa-miR-26a 17701.5 1134.3
hsa-let-7e 17673.3 2166.1
hsa-miR-768-3p:11.0 17642.0 2731.8
hsa-miR-100 17579.3 1745.4
hsa-let-7i 17241.8 804.4
hsa-miR-923 16997.3 3498.3
hsa-let-7b 16807.8 585.4
hsa-miR-222 16276.8 1295.1
hsa-miR-125a-5p 16050.5 1068.0
hsa-miR-199a-3p,hsa-miR-199b-3p 15980.3 1402.7
hsa-miR-92a 15764.3 650.1
hsa-let-7c 15695.5 2136.7
hsa-miR-151-5p 15560.0 1490.1
hsa-miR-23b 15545.5 2236.8
hsa-miR-1308 15318.5 2330.0
hsa-miR-196a 15272.8 645.1
hsa-miR-16 15181.3 1449.2
hsa-miR-25 15137.8 1294.5
hsa-miR-193a-5p 15061.8 978.5
hsa-miR-27a 15018.3 2589.6
solexa-555-1991 14762.5 897.6
hsa-miR-143 14714.8 1900.5
hsa-miR-15b 14409.3 884.1
HS_100 14373.3 1144.9
hsa-let-7d 14286.3 1618.1
hsa-miR-1274a 13864.0 1486.9
hsa-miR-145 13787.3 1564.7
hsa-miR-31 13704.5 1530.4
hsa-miR-574-3p 13679.8 1696.2
hsa-miR-152 13586.8 2963.6
hsa-miR-26b 13480.8 1235.7
hsa-miR-1260 13472.3 1928.7
hsa-miR-1246 13409.8 2074.7
hsa-miR-1826 13393.8 3269.9
HS_192.1 13391.0 2645.2
solexa-2952-306 13256.3 953.8
hsa-miR-424 13215.3 4095.2
hsa-miR-191 13163.8 1851.0
hsa-miR-197 12943.0 1094.8
hsa-miR-98 12607.5 1564.1
hsa-miR-199a-5p 12574.5 3478.1
HS_204.1 12545.0 1184.5
hsa-miR-29a 12474.3 2501.4
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Table 1 (continued )
TargetID Mean SD
HS_263.1 12208.3 2000.0
hsa-miR-224 11944.3 1349.4
hsa-miR-10b 11895.3 1703.7
hsa-miR-27b 11848.5 3310.9
hsa-miR-1201 11518.3 2715.9
hsa-miR-20a 11454.3 2086.0
hsa-miR-30d 11199.5 2248.6
hsa-miR-503 11092.3 1588.7
solexa-3464-254 11059.3 391.3
hsa-miR-132 10687.5 1492.4
hsa-miR-768-5p:11.0 10639.3 1341.5
hsa-miR-10a 10583.8 1824.0
hsa-miR-155 10402.0 2429.4
HS_243.1 10376.3 2551.2
hsa-miR-193b 10359.5 2138.7
hsa-miR-664 10341.0 1762.0
hsa-miR-432 10037.0 2265.1
hsa-miR-195 9968.0 2337.5
hsa-let-7d 9928.8 783.0
hsa-miR-29b-1 9900.3 1879.9
hsa-miR-34a 9880.8 2109.6
hsa-miR-99b 9711.8 2675.7
hsa-miR-30c 9600.3 2441.4
hsa-miR-134 9303.3 934.1
hsa-miR-93 9285.0 592.1
hsa-miR-382 9096.3 1240.3
hsa-miR-92b 8970.5 814.7
hsa-miR-151-3p 8963.0 1436.3
hsa-miR-484 8832.0 1093.8
hsa-miR-28-5p 8679.8 2117.9
hsa-miR-455-3p 8657.8 1939.9
hsa-miR-423-3p 8573.5 1260.9
hsa-miR-424 8397.5 1168.2
solexa-51-13984 8340.0 850.3
hsa-miR-409-3p 8295.8 866.6
HS_284.1 8291.0 1037.4
hsa-miR-374a 8283.5 2769.2
hsa-miR-30e 8194.8 2534.1
hsa-miR-1228 7994.8 492.6
hsa-miR-29b 7992.3 774.7
hsa-miR-148a 7992.0 3801.0
hsa-miR-185 7845.3 1517.6
hsa-miR-15a 7627.3 3472.2
hsa-let-7b 7564,8 881.2
hsa-miR-365 7544.3 1540.2
hsa-miR-493 7387.3 1028.6
hsa-miR-324-5p 7379.0 1880.9
hsa-miR-361-5p 7259.5 2303.2
hsa-miR-544 7162.3 3061.8
hsa-miR-324-3p 7112.3 1953.1
hsa-miR-30b 7072.0 1144.3
hsa-miR-379 6963.3 771.4
hsa-miR-342-3p 6835.3 1553.5
hsa-miR-99a 6792.0 3415.3
hsa-miR-22 6725.0 3846.5
hsa-miR-328 6488.0 1575.3
hsa-miR-151:9.1 6460.3 2527.1
hsa-miR-146a 6456.3 2689.7
solexa-539-2056 6418.3 3114.5
HS_96 6396.5 551.2
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Table 1 (continued )
TargetID Mean SD
hsa-miR-196b 6232.5 647.2
hsa-miR-181b 6187.5 2869.8
solexa-9029-92 6172.0 299.1
hsa-miR-423-5p 6119.0 1363.2
hsa-miR-615-3p 6081.8 332.8
hsa-miR-708 6033.8 2431.3
hsa-miR-411 5970.5 1412.8
hsa-miR-130b 5941.5 1460.8
hsa-miR-146b-5p 5919.0 3049.7
hsa-miR-329 5866.5 1477.3
solexa-8048-104 5741.5 2872.2
hsa-miR-22 5670.8 2076.8
hsa-miR-130a 5667.3 853.1
hsa-miR-181a 5661.5 4037.6
hsa-miR-199b-5p 5543.8 1838.6
hsa-miR-337-3p 5513.0 1579.9
hsa-miR-28-3p 5509.5 1213.1
hsa-miR-140-3p 5425.3 814.1
hsa-miR-1275 5317.8 1528.2
hsa-miR-218 5297.0 488.0
hsa-miR-30a 5277.8 2734.4
hsa-miR-106b 5075.3 1656.1
hsa-miR-425 4907.8 3170.9
hsa-miR-886-5p 4860.3 632.8
hsa-miR-17 4835.8 558.0
solexa-8211-102 4810.8 3885.4
solexa-499-2217 4718.8 514.6
hsa-miR-103 4697.0 1083.3
hsa-miR-574-5p 4654.8 1382.9
hsa-miR-594:9.1 4525.3 1320.1
hsa-miR-939 4440.3 524.5
hsa-miR-889 4371.3 835.2
hsa-miR-877 4359.5 2022.5
hsa-miR-145 4353.5 2399.0
hsa-miR-576-5p 4334.8 688.7
hsa-miR-744 4311.3 520.4
solexa-578-1915 4307.3 785.1
HS_188 4275.3 399.0
hsa-miR-331-3p 4249.8 507.8
hsa-miR-370 4245.3 941.4
hsa-miR-7 4233.0 887.0
hsa-miR-129-5p 4125.3 289.4
hsa-miR-127-3p 4077.5 1046.9
hsa-miR-625 4070.8 855.9
HS_108.1 4007.3 1646.7
HS_29 3980.5 1256.6
hsa-miR-518a-3p 3974.5 439.7
hsa-miR-542-3p 3970.3 2890.8
hsa-miR-1249 3959.0 1498.5
hsa-miR-106a 3835.0 825.1
hsa-miR-193b 3768.3 1340.9
hsa-miR-24-2 3718.0 1956.8
hsa-miR-532-3p 3716.8 1867.2
hsa-miR-128 3681.0 888.9
hsa-miR-628-5p 3673.0 1407.6
hsa-miR-29c 3658.8 2366.8
hsa-miR-663 3592.3 588.6
hsa-miR-625 3586.5 745.3
hsa-miR-204 3579.8 443.0
hsa-miR-30c-1 3551.8 1099.1
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TargetID Mean SD
hsa-miR-376c 3492.5 589.6
hsa-miR-221 3461.0 2028.3
hsa-miR-539 3454.3 466.6
hsa-miR-30a 3437.3 1699.3
hsa-miR-548b-5p 3402.5 343.6
hsa-miR-886-3p 3352.5 649.1
hsa-miR-7-1 3338.0 3726.7
hsa-miR-1300 3277.5 2082.2
hsa-miR-450a 3205.5 2247.8
hsa-miR-628-3p 3185.8 1065.8
hsa-miR-15b 3160.3 764.0
hsa-miR-130b 3152.0 1059.8
hsa-miR-372 3144.3 302.8
hsa-miR-433 3129.8 378.9
hsa-miR-335 3084.5 1863.3
hsa-miR-126 3052.3 703.7
hsa-miR-675 3024.3 591.5
hsa-miR-487b 3016.0 534.6
hsa-miR-16-2 3011.0 1345.6
hsa-miR-126 2964.3 2488.8
hsa-miR-299-5p 2726.3 738.4
hsa-miR-30e 2707.3 1939.7
hsa-miR-10a 2704.0 604.5
hsa-miR-31 2686.3 2011.9
hsa-miR-517a 2681.8 439.7
solexa-4793-177 2568.5 298.2
hsa-miR-421 2521.0 728.3
hsa-miR-342-5p 2514.5 439.7
hsa-miR-654-5p 2511.8 472.9
hsa-miR-940 2479.5 212.6
HS_239 2468.8 749.4
hsa-miR-143 2447.8 213.5
hsa-miR-138 2432.8 1123.8
hsa-miR-485-3p 2414.8 1197.9
hsa-miR-450b-5p 2403.8 1373.2
hsa-miR-137 2398.5 2711.8
HS_244 2385.8 156.3
hsa-miR-378 2350.5 611.8
HS_275 2310.3 174.3
hsa-miR-500 2307.8 1487.3
hsa-miR-499-5p 2305.3 367.1
hsa-miR-148b 2279.5 2879.8
hsa-miR-664 2117.5 660.3
hsa-miR-301a 2088.8 190.6
hsa-miR-214 2069.5 1221.0
hsa-miR-181a-2 2052.5 1471.7
hsa-miR-335 1995.0 1939.3
HS_38.1 1993.3 175.6
hsa-miR-29a 1978.5 1742.2
hsa-miR-362-3p 1967.5 421.5
hsa-miR-23a 1926.3 661.7
HS_152 1902.3 74.4
HS_303_a 1883.8 254.7
hsa-miR-548d-5p 1872.8 480.8
hsa-miR-339-5p 1872.3 419.9
hsa-miR-502-3p,hsa-miR-500 1848.5 321.7
hsa-miR-560:9.1 1840.8 249.8
hsa-miR-189:9.1 1812.8 638.2
hsa-miR-125b-1 1798.3 557.2
hsa-miR-585 1794.8 360.7
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TargetID Mean SD
hsa-miR-210 1787.5 616.7
hsa-miR-494 1746.5 766.3
hsa-miR-769-5p 1733.3 264.7
hsa-miR-532-5p 1717.5 465.2
HS_94 1704.8 219.0
hsa-miR-493 1696.3 786.1
hsa-miR-517c 1695.5 633.4
hsa-miR-565:9.1 1675.3 493.9
hsa-miR-454 1663.3 527.2
hsa-miR-323-3p 1660.8 616.3
solexa-9655-85 1649.5 120.6
hsa-miR-92b 1644.3 727.9
hsa-miR-1287 1643.0 272.5
hsa-miR-212 1632.3 810.2
HS_199 1621.5 211.5
hsa-miR-1307 1608.3 381.4
hsa-miR-154 1606.0 957.6
hsa-miR-1301 1584.5 285.1
hsa-miR-1284 1539.0 114.2
hsa-miR-485-5p 1535.8 381.7
hsa-miR-194 1534.8 88.7
hsa-miR-624 1526.8 622.9
hsa-miR-519b-3p 1509.8 95.1
HS_113 1492.0 41.2
HS_71.1 1466.5 89.0
hsa-miR-216b 1444.8 389.1
hsa-miR-1285 1442.0 443.3
HS_150 1428.5 143.1
hsa-miR-27b 1396.0 892.5
HS_268 1390.5 100.5
hsa-miR-133a 1384.5 203.6
HS_156 1361.5 984.0
HS_139 1354.8 105.8
HS_19 1354.0 97.7
hsa-miR-551a 1344.8 195.1
hsa-miR-505 1342.5 835.9
HS_184 1299.3 63.8
hsa-miR-1271 1277.0 806.7
hsa-miR-491-5p 1243.0 206.9
HS_114 1242.8 196.3
hsa-miR-381 1231.0 278.1
hsa-miR-627 1210.3 356.3
hsa-miR-181a 1200.3 46.4
hsa-miR-660 1192.0 1533.2
hsa-miR-1224-3p 1182.8 115.5
hsa-miR-449b 1178.3 39.1
hsa-miR-140-5p 1161.0 840.4
hsa-miR-1228 1158.3 214.7
hsa-miR-501-3p 1156.0 167.3
hsa-miR-548a-3p 1153.3 66.9
hsa-miR-1299 1153.0 185.4
hsa-miR-296-3p 1151.8 410.7
HS_32 1139.5 123.6
hsa-miR-1254 1130.5 125.3
hsa-miR-200c 1126.8 208.4
HS_81 1122.8 90.8
hsa-miR-671:9.1 1109.5 455.8
hsa-miR-34c-3p 1103.8 866.9
hsa-miR-1234 1097.5 302.5
hsa-miR-34b 1097.3 369.2
A. Eﬁmenko et al. / Data in Brief 6 (2016) 295–310 301
Table 1 (continued )
TargetID Mean SD
hsa-miR-125a-3p 1073.3 88.8
hsa-miR-1296 1071.8 354.0
hsa-let-7e 1068.8 429.2
hsa-miR-571 1065.8 110.0
hsa-miR-149 1061.5 533.1
HS_166.1 1056.8 305.9
hsa-miR-19b 1041.0 80.3
hsa-miR-298 1038.0 120.1
hsa-miR-1233 1037.5 183.0
hsa-let-7f-1 1036.5 333.0
hsa-miR-362-5p 1034.8 270.1
hsa-miR-99b 1034.5 449.7
hsa-miR-105 1021.0 259.3
hsa-miR-23b 999.8 338.4
hsa-miR-409-5p 997.5 728.5
hsa-miR-629 988.5 336.3
hsa-miR-369-5p 986.8 304.0
hsa-miR-602 983.8 75.8
hsa-miR-875-5p 982.3 130.0
hsa-miR-495 974.8 217.1
hsa-miR-584 969.3 310.9
hsa-miR-18a 957.5 786.4
hsa-miR-501-5p 957.3 246.6
hsa-miR-187 955.5 126.8
hsa-miR-1257 948.5 41.4
hsa-miR-25 947.5 141.3
hsa-miR-452:9.1 946.0 343.0
hsa-miR-1267 940.0 146.5
hsa-miR-505 926.8 575.6
hsa-miR-642 919.0 295.5
HS_10 918.5 780.9
hsa-miR-18a 916.8 353.2
hsa-miR-615-5p 912.5 284.8
hsa-miR-517 908.5 116.3
hsa-miR-26b 904.0 564.8
hsa-miR-890 896.5 71.4
hsa-miR-452 892.3 397.7
hsa-miR-431 889.5 179.5
hsa-miR-186 874.8 415.7
HS_303_b 863.8 241.4
hsa-miR-671-3p 862.3 430.5
hsa-miR-192 861.8 991.3
hsa-miR-609 859.8 29.5
hsa-miR-194 859.3 1047.4
HS_97 846.8 133.1
hsa-miR-369-3p 845.0 191.3
hsa-miR-942 844.5 187.6
HS_116 842.3 321.3
hsa-miR-34c-5p 831.8 186.6
hsa-miR-603 824.5 574.6
hsa-miR-27a 816.8 557.3
hsa-miR-766 809.5 249.5
HS_85.1 806.3 108.5
HS_260 797.8 173.7
hsa-miR-29c 797.8 204.0
hsa-miR-223 796.0 418.9
hsa-miR-106b 790.0 334.5
hsa-miR-550 783.3 208.7
hsa-miR-30d 781.8 93.6
hsa-miR-195 781.3 98.8
hsa-miR-654-3p 771.8 204.8
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TargetID Mean SD
hsa-miR-665 762.8 156.5
HS_208 757.5 72.5
hsa-miR-138-1 757.3 398.7
hsa-miR-302d 750.3 319.6
solexa-15-44487 749.5 58.3
hsa-miR-554 738.8 82.8
solexa-9081-91 734.5 42.2
hsa-miR-1204 720.5 64.3
hsa-miR-193a-3p 718.0 357.6
hsa-miR-549 713.8 393.5
hsa-miR-507 711.5 58.1
hsa-miR-497 710.3 339.4
HS_110 706.0 133.1
hsa-miR-361-3p 703.5 321.3
hsa-miR-663b 700.3 68.3
HS_250 697.8 120.2
hsa-miR-483-3p 694.8 312.6
hsa-miR-486-5p 685.0 276.9
hsa-miR-1305 684.8 58.5
hsa-miR-425 682.5 305.4
hsa-miR-545 677.8 116.9
hsa-miR-491-3p 675.8 62.8
HS_52 670.8 54.0
hsa-miR-573 658.5 20.5
hsa-miR-34a 654.8 305.1
hsa-miR-1286 651.3 43.5
HS_209.1 644.3 291.1
hsa-miR-598 643.8 240.9
hsa-miR-371-5p 643.3 68.0
hsa-miR-641 635.0 14.9
hsa-miR-525-3p 634.5 123.4
hsa-miR-655 633.5 296.8
hsa-miR-801:9.1 631.8 58.4
HS_78 626.8 69.8
hsa-miR-33a 625.3 43.6
hsa-miR-16-1 620.8 296.5
hsa-miR-652 619.0 213.5
hsa-miR-411 616.8 79.5
hsa-miR-1245 614.3 280.4
hsa-miR-302b 612.5 278.1
hsa-miR-518c 611.3 38.9
hsa-miR-1263 611.0 39.9
HS_262.1 606.0 33.8
hsa-miR-516a-3p,hsa-miR-516b 600.5 85.7
hsa-miR-513a-5p 598.5 29.9
hsa-miR-502-5p 594.5 192.1
hsa-miR-302b 590.5 107.0
hsa-miR-518d-3p 578.3 59.0
solexa-7534-111 577.5 222.6
hsa-miR-583 576.8 100.9
HS_24 573.5 315.9
hsa-miR-376a 573,5 183.2
hsa-miR-136 572.5 530.1
HS_20 571.3 46.5
hsa-miR-346 570.5 183.7
hsa-miR-576-3p 568.8 221.2
solexa-7509-112 564.0 40.9
HS_279_a 555.8 50.5
hsa-miR-659 548.5 83.4
hsa-miR-188-5p 546.5 120.0
solexa-9578-86 545.5 223.2
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Table 1 (continued )
TargetID Mean SD
hsa-miR-376a:9.1 540.3 236.5
HS_186 536.8 60.1
hsa-miR-379 535.0 218.6
hsa-miR-1225-3p 534.8 118.3
HS_305_b 526.5 115.1
hsa-miR-26a-2 525.3 337.8
solexa-1460-671 519.8 182.3
hsa-miR-525-5p 516.3 24.6
solexa-9124-90 509.0 124.0
hsa-miR-376a 504.8 315.1
hsa-miR-1180 501.8 55.2
hsa-miR-668 500.5 89.6
hsa-miR-101 500.3 103.7
hsa-miR-330-3p 500.0 130.0
HS_160 495.0 74.7
hsa-miR-542-5p 490.5 43.0
hsa-miR-518a-5p,hsa-miR-527 487.5 7.3
solexa-826-1288 487.3 120.0
hsa-miR-99a 487.0 38.7
HS_17 486.3 259.7
hsa-miR-1184 485.5 153.5
hsa-miR-520d-5p 479.0 34.3
hsa-miR-550 478.5 101.5
HS_287 473.5 119.3
hsa-let-7c 468.5 189.5
hsa-miR-374a 465.5 45.5
hsa-miR-651 462.0 49.0
solexa-8926-93 461.3 293.0
hsa-miR-200b 456.8 100.3
hsa-miR-17 449.5 78.6
hsa-miR-19b-2 448.0 17.3
HS_252.1 444.8 12.3
hsa-miR-218-1 444.8 38.8
hsa-miR-616 437.5 247.5
hsa-miR-1226 434.5 133.6
hsa-miR-1225-5p 429.8 321.2
hsa-miR-21 428.3 357.3
hsa-miR-376b 423.0 55.8
hsa-miR-122 421.5 33.6
hsa-miR-30c-2 421.0 134.6
hsa-miR-647 418.8 69.6
hsa-miR-132 418.5 288.2
hsa-miR-367 416.3 17.6
HS_276.1 412.8 50.3
solexa-3022-299 409.0 26.0
hsa-miR-941 408.5 154.1
hsa-miR-299-3p 407.8 54.0
HS_60 406.5 89.3
hsa-miR-591 406.5 28.0
hsa-miR-1197 404.5 91.6
hsa-miR-340 403.8 242.4
HS_142.1 402.0 82.7
hsa-miR-139-5p 399.3 257.8
solexa-3126-285 398.8 184.2
HS_145.1 395.5 30.6
hsa-miR-1294 395.0 95.9
hsa-miR-30b 395.0 129.0
HS_105 394.3 44.1
hsa-miR-1268 393.0 68.3
hsa-miR-302c 392.8 15.3
HS_203 384.8 25.9
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TargetID Mean SD
hsa-miR-629 384.5 213.8
hsa-miR-518e:9.1 384.3 29.2
HS_126 383.5 34.6
hsa-miR-410 382.5 217.5
HS_149 380.8 167.1
hsa-miR-545:9.1 378.8 140.1
HS_48.1 377.8 65.3
hsa-miR-1207-5p 376.3 32.7
hsa-miR-516a-5p 372.8 60.1
hsa-miR-377 369.0 77.0
HS_196.1 368.5 117.1
hsa-miR-182 368.0 92.5
hsa-miR-452 367.8 29.0
HS_27 363.5 15.6
hsa-miR-564 360.8 60.5
HS_219 351.8 63.6
HS_285 350.3 87.8
hsa-miR-1322 348.8 81.7
hsa-miR-1206 348.0 25.7
hsa-miR-1243 347.0 72.4
hsa-miR-614 345.3 39.1
HS_25 34.8 70.5
hsa-miR-92a-1 340.8 119.4
hsa-miR-296-5p 337.8 54.2
hsa-miR-1248 332.5 86.2
hsa-miR-144 331.5 23.9
HS_6 328.3 74.8
hsa-miR-128a:9.1 326.3 122.1
solexa-5874-144 326.3 35.0
hsa-miR-567 324.0 19.4
hsa-miR-202:9.1 323.3 131.5
hsa-miR-220b 323.0 101.0
HS_90 319.3 26.8
hsa-miR-653 316.3 14.3
hsa-let-7a 313.0 162.2
hsa-miR-107 310.8 109.9
HS_99.1 309.3 51.0
HS_201 307.5 105.4
hsa-miR-767-5p 306.5 38.6
hsa-miR-34b 305.0 43.5
hsa-miR-222 304.8 34.2
hsa-miR-935 303.8 45.1
HS_2 303.5 65.8
HS_122.1 299.5 16.6
hsa-miR-454 297.3 86.9
hsa-miR-181c 296.3 53.6
hsa-miR-380 294.0 38.9
hsa-miR-326 293.5 84.4
hsa-miR-339-3p 293.0 72.7
hsa-miR-338-5p 291.0 28.2
hsa-miR-100 285.8 63.8
hsa-miR-1231 283.5 33.4
HS_138 279.5 21.4
hsa-miR-887 278.3 36.9
hsa-miR-1273 276.0 127.5
hsa-miR-129-3p 275.5 107.2
hsa-miR-1237 274.0 116.0
HS_119 271.0 25.6
hsa-miR-646 268.5 109.8
HS_40 261.8 33.6
hsa-miR-1304 256.0 79.5
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TargetID Mean SD
hsa-miR-384 255.5 17.2
hsa-miR-371-3p 251.8 143.6
hsa-miR-377 250.5 44.9
hsa-miR-760 250.5 47.3
hsa-miR-455-5p 249.0 129.0
hsa-miR-147b 248.3 21.7
hsa-miR-1323 248.0 22.9
hsa-miR-219-2-3p 246.8 24.5
hsa-miR-596 246.3 42.0
hsa-miR-581 242.0 28.9
hsa-miR-519c-3p 237.3 30.7
hsa-miR-9 234.3 46.0
HS_153 232.8 11.0
hsa-miR-1272 232.5 24.2
hsa-miR-769-3p 230.3 140.8
hsa-miR-643 227.3 25.3
hsa-miR-520a-3p 222.3 30.6
HS_23 221.8 25.9
hsa-miR-323-5p 221.8 55.4
hsa-miR-559 221.0 13.5
hsa-miR-345:9.1 220.8 110.5
hsa-miR-1297 220.5 15.5
hsa-miR-412 218.3 13.7
hsa-miR-624 218.3 18.0
hsa-miR-548c-5p 210.3 36.5
hsa-miR-563 210.3 34.9
hsa-miR-876-3p 208.0 29.9
hsa-miR-135b 207.8 42.0
HS_200 201.3 28.0
hsa-miR-1208 198.0 33.8
hsa-miR-383 196.8 80,2
hsa-miR-453 196.0 23.8
HS_141 195.0 25.1
hsa-miR-331-5p 193.8 11.0
HS_33 193.3 18.0
hsa-miR-548f 189.3 25.2
hsa-miR-206 188.8 17.0
hsa-miR-190 180.8 5.6
hsa-miR-548m 177.5 21.3
hsa-miR-592 171.8 14.8
hsa-miR-1262 159.0 13.3
Fig. 1. MSC viability. MSC transfected with pre-miR-92a, anti-miR-92a or scramble oilgos were grown for 48 h post-trans-
fection. The portion of viable cells were calculated as a number of Trypan-blue excluding cells per 100 MSCs using Countess Cell
Counter, Invitrogen.
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Fig. 2. Angiogenic factors content in MSCs 48 h after transfection with either scramble oligos (scramble), pre-miR-92a (pre-
miR92a) or anti-miR-92a (anti-miR92a). The content of HGF and angiopoietin-1 in cell lysates was measured by ELISA and
normalized to cell counts. Presented are data of 3 experiments. *po0.05 vs. scramble transfected cells.
Fig. 3. HUVEC viability in the conditioned medium of MSC transfected with pre-miR-92a, anti-miR-92a or scramble oilgos. The
portion of viable cells was calculated as a number of Trypan-blue excluding cells per 100 cells.
A. Eﬁmenko et al. / Data in Brief 6 (2016) 295–310 3072 Experimental design, materials and methods
2.1 Cell culture
MSCs were isolated from subcutaneous fat tissue of healthy young donors using enzymatic
digestion as previously described [2]. All donors gave their informed consent and the local ethics
committee approved the study protocol. Cells were cultured in AdvanceSTEMMesenchymal Stem Cell
Media containing 10% AdvanceSTEM Supplement (HyClone), 1% antibiotic–antimycotic solution
(HyClone) at 37 °C in 5% CO2 incubator. Cells were passaged at 70% conﬂuency using HyQTase solution
(HyClone). For the experiments, MSCs cultured up to 3rd–4th passages were used.
Human umbilical vein endothelial cells (HUVEC) were isolated from human umbilical cord vein as
previously described [3]. Cells were cultured on gelatin-coated plastic in endothelial growth medium
(EGM-2, Lonza) and used for experiments at 3–4 passages.
2.2 miRNA isolation, hybridization and real-time PCR
Total RNA was extracted from MSCs with Ambions mirVana™ miRNA Isolation Kit according to
manufacture instruction. 200 ng of total RNA was processed according to MicroRNA Assay Guide
(Illumina) using Human v2 microRNA panel (1146 probes). Data acquisition and analysis of evidently
expressed microRNA were performed by GenomeStudio software (Illumina) using gene expression
Fig. 4. Capillary-like tubules formation in the presence of MSC conditioned medium. Representative microphotographs of
capillary-like tubules formed in growth medium without serum (negative control), in the presence of 10% FBS (positive con-
trol), in the presence of conditioned medium of MSCs transfected either with scramble oligos (scramble), anti-miR-92a (anti-
miR92a), pre-miR-92a (pre-miR92a). Conditioned medium of MSCs overexpressing pre-miR-92a with addition of recombinant
human HGF and HGF alone was also used. Graph represents morphometric analysis of capillary-like structures total length per
view ﬁeld. Presented are data of 3 experiments. *po0.05 vs. conditioned medium of MSCs transfected with pre-miR-92a.
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was detected using miRVana qRT-PCR miRNA detection kit (Ambion), according to manufacturer's
protocol. Reverse transcription was performed during 30 min at 37 °C using 25 ng of RNA and hsa-
miR-92a RT-Primer (Ambion). Real-time PCR was performed using hsa-miR92a – qRT-PCR assay
primer (Ambion) and ready-to-use reaction mix, containing DNA polymerase, SYBR Green and ROX
(Evrogen) in 7500 Fast Real-time PCR system (Applied Biosystems).
2.3 Cell viability
Viability of MSCs transfected with pre-miR-92a, anti-mi-92a or scramble oligos was assessed 48 h
post-transfection. HUVEC viability was analyzed after 24 h incubation in the conditioned medium of
Fig. 5. Capillary-like tubules formation in the presence of MSC conditioned medium. Representative microphotographs of
capillary-like tubules formed in growth medium without serum (negative control), in the presence of 10% FBS (positive con-
trol), in the presence of conditioned medium of MSCs transfected either with scramble oligos (scramble), pre-miR-92a (pre-
miR92a) or anti-miR-92a (anti-miR92a) or in the presence of conditioned medium from transfected cells after removing
extracellular vesicles by ultracentrifugation.
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A. Eﬁmenko et al. / Data in Brief 6 (2016) 295–310310MSCs. To assess the viability cells were trypsinized and counted using Trypan blue staining on
Countess Automated Cell Counter.
2.4 in vitro tube formation assay
HUVEC were seeded in 48-well plates coated with growth factor reduced Matrigel (BD Bioscience,
150 ml per well) in concentration 2104 cells per well and MSC conditioned media (300 ml per well)
were added [4]. Three wells were used for each sample of conditioned medium. Supplement-free
serum-free endothelial basal medium (EBM-2, Lonza) was utilized as a negative control; endothelial
growth medium (EGM-2, Lonza) with 10% of FBS served as positive control. Plates were placed into
CO2-incubator at 37 °C and capillary-like structures were assayed in 24 h under the light microscope
(Leica). Total length of tubular structures was counted in 5 random ﬁelds of view per well (objective
10 ) using MetaMorph 5.0 software (Universal Imaging).
To evaluate a signiﬁcance of HGF and angiopoietin-1 for tube formation we also supplemented the
conditioned medium of MSCs overexpressing miR-92a with recombinant growth factors (R&D). To
examine an impact of extracellular vesicles on angiogenic action of MSC conditioned medium, we
removed them by ultracentrifugation as described in [4].
2.5 ELISA of HGF and angiopoietin-1
Concentrations of HGF and angiopoetin-1 in lysates of MSCs transfected with pre-miR-92a
(Ambion), anti-miR-92a or pre-miR negative control 1 were measured using ELISA kits (R&D Sys-
tems) according to manufacturer instructions.Acknowledgments
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